- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06748976
Modulation of Cortical Brain Activity During Attentional Control
EEG Alpha Rhythm Modulation Using Sham Neurofeedback During Attentional Control in a Virtual Reality Environment
The goal of this study is to determine whether an open-loop sham neurofeedback system can effectively modulate EEG alpha rhythms, which are associated with attentional control. The main questions it aims to answer are:
Does positive sham neurofeedback lead to a decrease in relative EEG alpha power compared to a control condition without feedback?
Researchers will compare the effects of positive and negative sham-neurofeedback conditions to a control condition without feedback to assess the system's impact on alpha rhythm modulation. Participants will:
Experience three conditions (positive sham-neurofeedback, negative sham-neurofeedback, and no feedback) within a virtual reality environment.
Undergo EEG recordings to measure changes in alpha power as a marker of attentional resource allocation.
Provide written informed consent and complete the study following ethical guidelines.
This study seeks to explore the potential of open-loop feedback systems to enhance attentional control by modulating alpha rhythm.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: José Alberto Biurrun Manresa, PhD
- Phone Number: +543434975100120
- Email: jose.biurrun@uner.edu.ar
Study Locations
-
-
Entre Ríos Province
-
Oro Verde, Entre Ríos Province, Argentina, 3100
- Recruiting
- Facultad de Ingeniería, Universidad Nacional de Entre Ríos
-
Contact:
- José Alberto Biurrun Manresa, PhD
- Phone Number: +543434975100
- Email: jose.biurrun@uner.edu.ar
-
Principal Investigator:
- José Alberto Biurrun Manresa, PhD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
The study will include adults aged between 18 and 60 years, selected from the city of Paraná and surrounding areas. The population will be balanced in terms of age and gender, ensuring representation across two age groups (18-40 years and 41-60 years).
Participants will be recruited through:
- Word-of-mouth.
- Social media platforms.
- University mailing lists and community boards. Initial contact will be made via telephone or email, where potential participants will be provided with detailed information about the study's purpose, procedures, and eligibility criteria. Recruitment materials and communications will describe the study as a conventional neurofeedback experiment to maintain participant naivety about the specific hypotheses and experimental conditions.
Description
Inclusion Criteria:
- Adults aged between 18 and 60 years.
- Normal or corrected vision.
- Ability to provide written informed consent.
Exclusion Criteria:
- Diagnosed with photosensitive epilepsy.
- Significant hearing loss or diagnosed hearing impairment.
- Current psychiatric illness or disorder.
- History of migraines or chronic headaches.
- History of substance or alcohol abuse.
- Currently pregnant.
- Discomfort with using a virtual reality headset, assessed during a pilot session.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Healthy
Volunteers: Adults aged 18-60 years with normal or corrected vision, no clinical history of photosensitive epilepsy, psychiatric disorders, significant hearing loss, migraines, or substance abuse. Interventions: Positive sham-neurofeedback Negative sham-neurofeedback Control (no feedback) |
Participants receive simulated positive reinforcement feedback designed to mimic successful modulation of EEG alpha rhythms, despite the feedback not being directly based on their actual neural activity.
This condition aims to create the perception of improved attentional control.
Participants receive simulated negative reinforcement feedback that mimics unsuccessful modulation of EEG alpha rhythms, regardless of their actual neural activity.
This condition is intended to simulate reduced attentional control.
Participants perform the same attentional task but without receiving any feedback.
This condition serves as a baseline to evaluate the effects of the sham neurofeedback interventions on EEG alpha rhythm modulation.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Relative alpha power
Time Frame: Immediately after intervention
|
The primary outcome of the study is the change in relative EEG alpha power during the positive sham-neurofeedback condition compared to the control condition (no feedback).
A decrease in relative alpha power is interpreted as an indicator of increased attentional resource allocation, reflecting enhanced attentional control.
This measure is derived from EEG recordings captured during the experimental tasks in each condition.
|
Immediately after intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Relative alpha power
Time Frame: Immediately after intervention
|
The secondary outcome of the study is the change in relative EEG alpha power during the negative sham-neurofeedback condition compared to the control condition (no feedback).
|
Immediately after intervention
|
Collaborators and Investigators
Publications and helpful links
General Publications
- Knowles MM, Wells A. Single Dose of the Attention Training Technique Increases Resting Alpha and Beta-Oscillations in Frontoparietal Brain Networks: A Randomized Controlled Comparison. Front Psychol. 2018 Sep 20;9:1768. doi: 10.3389/fpsyg.2018.01768. eCollection 2018.
- Magosso E, Ricci G, Ursino M. Modulation of brain alpha rhythm and heart rate variability by attention-related mechanisms. AIMS Neurosci. 2019 Mar 4;6(1):1-24. doi: 10.3934/Neuroscience.2019.1.1. eCollection 2019.
- Enriquez-Geppert S, Smit D, Pimenta MG, Arns M. Neurofeedback as a Treatment Intervention in ADHD: Current Evidence and Practice. Curr Psychiatry Rep. 2019 May 28;21(6):46. doi: 10.1007/s11920-019-1021-4.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Pain
- Neurologic Manifestations
- Musculoskeletal Diseases
- Nervous System Diseases
- Muscular Diseases
- Mental Disorders
- Neuromuscular Diseases
- Rheumatic Diseases
- Digestive System Diseases
- Gastrointestinal Diseases
- Feeding and Eating Disorders
- Pathological Conditions, Signs and Symptoms
- Signs and Symptoms
- Rumination Syndrome
- Fibromyalgia
- Chronic Pain
Other Study ID Numbers
- IS004817
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
- ANALYTIC_CODE
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Pain
-
University Rovira i VirgiliMinisterio de Ciencia e Innovación, SpainNot yet recruitingChronic Post-operative Pain | Chronic Postsurgical Pain | Chronic Post-surgical Pain | Chronic Postoperative PainSpain
-
Pain ConcernThe Thistle Foundation; Health and Social Care Alliance Scotland (the ALLIANCE) and other collaboratorsCompletedChronic Pain | Chronic Pain Syndrome | Chronic Pain, Widespread | Chronic Pain Due to Trauma | Chronic Pain Due to Malignancy (Finding) | Chronic Pain Due to Injury | Chronic Pain Post-Procedural | Chronic Pain HipUnited Kingdom
-
Bjorn AngKarolinska Institutet; The Swedish Research Council; Göteborg University; Forte; Dalarna...Not yet recruitingPain Management | Pain, Chronic | Chronic Pain, WidespreadSweden
-
University of FaisalabadNot yet recruiting
-
Universidade do Vale do ParaíbaCAPES Foundation - Ministry of Education, Brazil.Enrolling by invitationChronic Low Back Pain | Chronic Shoulder Pain | Chronic Knee PainBrazil
-
Vastra Gotaland RegionCompletedPain, Chronic | Widespread Chronic PainSweden
-
Washington D.C. Veterans Affairs Medical CenterRecruitingChronic Back Pain | Chronic Pain (back / Neck)United States
-
Connecticut Children's Medical CenterRecruitingChronic Pain | Pain, Chronic | Chronic Pain SyndromeUnited States
-
The University of Texas Health Science Center,...RecruitingJoint Pain | Chronic Knee Pain | Chronic Pain (Back / Neck) | Chronic Pain ManagementUnited States
-
University of Alabama, TuscaloosaPatient-Centered Outcomes Research Institute; East Carolina University; Whatley...CompletedPain | Chronic Pain | Chronic Pain Syndrome | Widespread Chronic Pain | Chronic Pain Due to InjuryUnited States
Clinical Trials on Positive sham neurofeedback
-
Kowloon Hospital, Hong KongChinese University of Hong KongCompletedStroke | Cognitive ImpairmentHong Kong
-
University of Rhode IslandCompletedNeurofeedbackUnited States
-
University of OxfordWellcome TrustTerminated
-
ETH ZurichSwiss Epilepsy Centre - Klinik LenggRecruitingHealth, Subjective | Epilepsy, Temporal Lobe | Psychogenic SeizureSwitzerland
-
Laureate Institute for Brain Research, Inc.National Institute of General Medical Sciences (NIGMS)TerminatedDepressive Disorder, MajorUnited States
-
Tel-Aviv Sourasky Medical CenterUnknown
-
University of HartfordCompleted
-
Central Institute of Mental Health, MannheimUniversity Hospital Tuebingen; University of Giessen; University Medical Center...RecruitingBorderline Personality DisorderGermany
-
Philipp StämpfliCompleted
-
Pedro MorgadoHospital de Braga; Clinical Academic Center (2CA)UnknownObsessive-Compulsive Disorder | OCDPortugal